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Bullous pemphigoid is an in¯ammatory subepider-
mal blistering skin disease associated with an IgG
autoimmune response to the type XVII collagen.
The immunopathologic features of bullous pemphi-
goid can be reproduced in mice by the passive trans-
fer of anti-type XVII collagen antibodies. In this
model, it is thought that blister formation depends
upon complement activation, neutrophil recruit-
ment, and some proteolytic enzymes. In this study,
we cloned hamster type XVII collagen cDNA, which
contains a 4296 bp coding region and which is pre-
dicted to be a transmembrane protein with an extra-
cellular collagenous domain, residing in type II
orientation. Antipeptide antibodies (anti-1191 IgG)
were obtained against a segment of hamster type
XVII collagen homologous with the human type
XVII collagen autoantibody-reactive site. The anti-
peptide antibodies were passively transferred to neo-
natal Syrian hamsters. The injected hamsters
developed a microscopic subepidermal blister as seen
previously in the mice. In order to test whether anti-
gen±antibody complexes and complement initiate
the subepidermal blister formation, we carried out
experiments in vitro on condition that in¯ammatory
cells were completely eliminated. Complement activ-
ation in sera was inhibited either by heating (at 56°C
for 30 min) or by preincubating with cobra venom
factor. When the hamster skin was incubated with
fresh anti-1191 antisera, separation of dermal±epider-
mal junction was observed. The anti-1191 IgG failed
to induce C3 deposition and dermal±epidermal junc-
tion separation, however, if the anti-1191 IgG was
added alone or complement activation in sera was
inhibited. Under these conditions, IgG but not C3
was deposited on the basement membrane. These
results strongly suggest that antigen±antibody com-
plexes and complement initiate dermal±epidermal
junction separation. Key words: autoimmunity/basement
membrane/collagen/skin. J Invest Dermatol 118:485±492,
2002
B
ullous pemphigoid (BP) is an autoimmune bullous
dermatosis characterized by subepidermal blisters, a
dermal in¯ammatory in®ltrate, and the deposition of
autoantibodies and complement along the dermal±
epidermal junction (DEJ) (Jordon et al, 1967).
Ultrastructural studies have shown that the DEJ separation in BP
lesions occurs through the lamina lucida, the electron-lucent region
that separates the basal cell plasma membrane from the underlying
basal lamina (Schaumburg-Lever et al, 1972; Dvorak et al, 1982).
This split is accompanied by an extensive in¯ammatory in®ltrate
and the destruction of hemidesmosomal and extracellular matrix
components (Schaumburg-Lever et al, 1972; Dvorak et al, 1982;
Anhalt and Morrison, 1993).
One of the main antigenic targets of BP autoantibodies is a
180 kDa hemidesmosome-associated glycoprotein designated as
type XVII collagen (also known as BPAG2 or BP 180). It consists
of an intracellular domain at its N-terminus, a transmembranous
segment, and an extracellular domain (Mutasim et al, 1985; Labib
et al, 1986; Diaz et al, 1990; Giudice et al, 1991, 1992). The
extracellular domain of type XVII collagen contains a series of
collagenous domains that is interrupted by 16 (14 in murine) minor
noncollagenous (NC) domains at the C-terminus (Giudice et al,
1991; Li et al, 1993). Structural studies have shown that the type
XVII collagen ectodomain exists in a multimeric rod-like con-
formation (Hirako et al, 1996; Balding et al, 1997). BP
autoantibodies react with at least four distinct antigenic sites on
the type XVII collagen ectodomain, all of which are clustered
within a 45 amino acid NC stretch in the NC16A domain adjacent
to the transmembrane domain (Giudice et al, 1993; Zillikens et al,
1997).
Liu et al (1993) have described a mouse model of BP that
involves the passive transfer of antibodies directed against mouse
type XVII collagen. Neonatal BALB/c mice injected with these
antibodies develop a blistering skin disease that exhibits all of the
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key immunopathologic features of BP. Using this animal model,
the researchers have shown that the antibody-induced lesion
formation is dependent on complement activation (Liu et al, 1995)
and the neutrophil in®ltration of the upper dermis (Liu et al, 1997).
The blockage of neutrophil recruitment into skin sites resulted in
the neutralization of the pathogenic activity of antimouse type
XVII collagen antibodies in mice. Proteinases and reactive free
radicals from in®ltrating in¯ammatory cells have been implicated as
effector molecules contributing to tissue damage in BP lesions
(Jordon et al, 1985; Gammon, 1989). Neutrophil granules contain a
variety of proteolytic enzymes, including elastase, cathepsin G,
collagenase, and gelatinase B, which are known to degrade speci®c
proteins of the extracellular matrix (Senior and Campbell, 1983;
Janoff, 1985; (Weiss, 1989). Upon cell activation, these enzymes
are secreted into the pericellular space (Weiss, 1989). The DEJ
separation triggered by pathogenic anti-type XVII collagen IgG
could be due to the proteolytic activity of the neutrophil elastase
alone or in concert with gelatinase B, cathepsin G, and/or other
proteolytic enzymes (Liu et al, 2000).
It is possible, however, that the complex of the anti-type XVII
collagen IgG and the complement by itself damages epidermal basal
cells to trigger clinical blister formation, because the deposition of
C3 on the antigen±antibody complexes induces the assembly of the
C5b-9 complex (Podack et al, 1982). The C5b-9 complex damages
basal cells and may initiate blister formation in BP.
We cloned the hamster type XVII collagen cDNA and obtained
antipeptide antibodies against the antigenic sites of the molecule.
Using the antibodies we investigated the initial step of blister
formation in vitro. The examination revealed that incubation of the
skin caused DEJ separation with the antibodies in the presence but
not in the absence of the complement.
MATERIALS AND METHODS
cDNA cloning and sequence analysis We isolated hamster type
XVII collagen cDNA with a polymerase chain reaction (PCR) cloning
strategy. The total RNA was extracted from neonatal hamster skin
(under 24 h old) using ISOGEN (Wako Pure Chemical Industries,
Osaka, Japan). The ®rst strand cDNA was reverse transcribed from the
RNA using RNA LA PCR kit ver. 1.1 (Takara, Shiga, Japan). PCR
ampli®cation of the cDNA was achieved with primers and LA Taq
DNA polymerase (Takara). The primers were designed on highly
conserved regions of type XVII collagen cDNA of both humans and
mice. To extend the nucleotide sequence toward the 5¢ end of the
cDNA, rapid ampli®cation of the cDNA 5¢ end (RACE) was applied.
For the RACE cloning, hamster double strand cDNA with a 5¢ blunt
end was synthesized using DNA synthesis module RPN 1256
(Amersham Life Sciences, Buckinghamshire, U.K.), and the 5¢ blunt end
cDNA was combined with oligonucleotides 5¢-GTAATACGACTC-
ACTATAGGGCACGCGTGGTCGACGGCCCGGGCTGGTG-3¢ and
HN-CCCGACCAC-PO4. The adapter-linked cDNA was ampli®ed by
PCR using the sense primer 5¢-AATACGACTCACTATAGGGCA-
CGCGTGGTC-3¢, which binds to the adapter sequence, and the
antisense primer, 5¢-AGATGCGAGTTCCTTCCGTGGGTACTC-
AGG-3¢.
Similar strategies were utilized to clone the 3¢ end of the type XVII
collagen cDNA. Speci®cally, the ®rst round of PCR was carried out
with a sense primer, 5¢-ATCGGCCCAGGAGGAGGTTATG-3¢ and an
antisense primer, 5¢-GTTTTCCCAGTCACGAC-3¢ (M13 primer M4;
Takara). After this ampli®cation, nested PCR was performed with the
nested sense primer oligomer with the sequence 5¢-CTGGAGACC-
TGGATTACAAC-3¢ and M13 primer M4 using the prior PCR product
as a template. The PCR product was cloned into vector pGEM-T Easy
(Promega, Madison, WI) and subjected to DNA sequence analysis.
Chemical synthesis of oligopeptide In human pemphigoid, the 45
amino acid stretch of type XVII collagen contains all the major epitopes
of the molecule (Zillikens et al, 1997). We cloned hamster type XVII
collagen cDNA and compared the deduced amino acid sequence with
that of human type XVII collagen to identify the hamster type XVII
collagen epitope. The epitopes, amino acids 495±512 and 513±532,
peptides 1190 and 1191, respectively, were synthesized on an Applied
Biosystems 430 A peptide synthesizer. The peptides were then puri®ed
by using a reverse-phase high performance liquid chromatograph
(Applied Biosystems model 150 A) equipped with an Aquapore Prep-10
C-8 column with a linear gradient of 0%±60% acetonitrile in 0.1% (vol/
vol) tri¯uoroacetic acid.
Immunization and immunologic assays Antisera were obtained
from young adult rabbits immunized with peptides 1190 and 1191, and
were tested for binding with hamster type XVII collagen by immunoblot
analysis. They were puri®ed through af®nity chromatography on
immobilized peptide columns.
Indirect immuno¯uorescence Sera obtained from immunized rabbits
and puri®ed anti-1191 IgG were assayed for antibody titers by indirect
immuno¯uorescence using neonatal hamster skin as substrate (Roscoe et
al, 1985).
Preparation of hamster skin extracts The neonatal Syrian hamster
skin was washed with cold phosphate-buffered saline (PBS) and the
dermis was removed as much as possible. The skin was cut into strips
and incubated in PBS containing 2 mM ethylenediamine tetraacetic acid
and 1 mM phenylmethylsulfonyl ¯uoride (PMSF) at 4°C for 48 h with
one buffer change. The epidermis was separated and extracted according
to the method described by Labib et al (1986), but with several
modi®cations. Brie¯y, the epidermis was homogenized on ice for 30 min
with 5 ml of 1.5% sodium dodecyl sulfate (SDS), 0.01 M Tris±HCl
buffer (pH 6.8) supplemented with 5% 2-mercaptoethanol, 2 mM PMSF
(Sigma Chemical, St. Louis, MO), and 10 mg per ml of pepstatin A,
antipain, leupeptin, and chymostatin (Sigma Chemical). This was boiled
for 5 min and centrifuged at 15,000g for 30 min. The supernatant was
harvested and stored at ±80°C until use.
Immunoblotting The skin extracts and sera were analyzed by SDS
polyacrylamide gel electrophoresis (PAGE) under reducing conditions
and nonreducing conditions, respectively, according to the method of
Laemmli (Laemmli, 1970). Immunoblotting was carried out as described
by Towbin et al (1992). Antipeptide antisera were diluted 10-fold with
TBS buffer.
Administration of the anti-1191 IgG and animal evaluation
Neonatal Syrian hamsters (under 24 h old) were injected intraperitoneally
with the puri®ed anti-1191 IgG or control IgG. Doses of the anti-1191
IgG ranged from 0.04 to 5.0 mg per g body weight, and the dose of the
control IgG was 5.0 mg per g body weight. The hamsters were
examined 24 h after the intraperitoneal injection of anti-1191 IgG. The
cutaneous change was examined by the extent of epidermis being lifted
away from the dermis by tweezers. For histochemical and
immunohistochemical studies, the non-®xed hamster skin was frozen in
OCT compound. Sections of the skin were incubated with biotinylated
anti-rabbit IgG. After the incubation they were washed with PBS and put
back into incubation with horsesradish-peroxidase-labeled streptavidin.
Goat anti-human C3 antibody was found to cross-react with hamster C3
on immunoblotting (data not shown). Therefore, the deposition of C3
was examined with goat antihuman C3 antibody and peroxidase antigoat
IgG. This process was followed by a reaction with diaminobenzidine and
counterstained with hematoxylin.
Incubation of hamster skin in the immunized serum The skin was
obtained from neonatal hamsters (24 h old) and cut into 10 3 10 mm
strips with a razor blade. They were incubated with fresh anti-1191
antisera, heat-inactivated (at 56°C for 30 min) fresh anti-1191 antisera,
anti-1191 antisera preincubated (at 37°C for 60 min) with 2.5 unit cobra
venom factor (CVF) (Venom Supplies, Tanunda, Australia), heat-
inactivated fresh anti-1191 antisera plus fresh normal rabbit sera, puri®ed
anti-1191 IgG plus Dulbecco's modi®ed Eagle's medium (DMEM),
puri®ed anti-1191 IgG plus fresh normal rabbit sera, and puri®ed anti-
1191 IgG plus fresh normal rabbit sera preincubated with CVF or
control nonimmunized rabbit sera at 37°C for 12 h. All sera and puri®ed
Figure 1. Hamster type XVII collagen cDNA and the deduced amino acid sequence. The deduced amino acid sequence revealed that hamster
type XVII collagen consists of a large NC domain (NC-1), amino acids 1±569, and a C-terminal collagenous domain consisting of 14 separate segments
with a Gly-X-Y repeating sequence (underlined). The NC-1 domain is predicted to contain the transmembrane domain (amino acids 472±493, bold
and underlined). The six potential N-glycosylation sites are shown in bold face.
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Figure 2. Direct comparison of the hamster, human, mouse, and
canine deduced amino acid sequences of type XVII collagen. The
hamster transmembrane domain (bold) is identical to those of human,
mouse, and canine. The antigenic site on type XVII collagen was not
conserved among hamster, human, mouse, and canine (box).
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anti-1191 IgG used on incubation with skin strips were reactive up to
1:320 dilution by indirect immuno¯uorescence. At the end of the
incubation, the skin strips were rinsed with PBS and frozen in OCT
compound.
RESULTS
The hamster type XVII collagen cDNA sequence and
comparison of hamster, human, murine, and canine type
XVII collagen amino acid sequence Hamster type XVII
collagen cDNA and amino acid sequences are shown in Fig 1. The
coding region of the cDNA was 4296 nucleotides in length. The
nucleotide sequence of the cDNA was submitted to the GenBank
database (accession number AB027759). Examination of the 5¢
nucleotide sequence indicated that the deduced N-terminal region
of the type XVII collagen polypeptide consisted of a NC segment
of 569 amino acids, designed as the NC-1 domain (Fig 1). By
using three independent computer programs we predicted the
presence of one transmembrane domain within the NC-1 with a
cytoplasmic N-terminal (Cserzo et al, 1997; Hirokawa et al, 1998;
Nakai and Horton, 1999). Similarly to that in humans, mice, and
canines, hamster type XVII collagen is considered to be a
transmembrane protein with type II orientation (Giudice et al,
1992; Li et al, 1993; Xu et al, 2000).
Downstream of NC-1, 14 separate collagenous domains with a
characteristic Gly-X-Y repeat were identi®ed. The sizes varied
from 9 to 242 amino acids (Fig 1). These collagenous domains
were separated by various sizes (4±56 amino acids) of NC
interruptions. The total number of amino acids in the collagenous
domain (570±1432) was 863, representing the C-terminal portion
of the molecule. Primary sequence analyses of the deduced hamster
type XVII collagen amino acid revealed the presence of six
potential N-glycosylation sites (Fig 1).
Human and mouse type XVII collagen were shown to consist of
1497 and 1433 amino acids, respectively, and 709 amino acids were
deduced from partial canine type XVII collagen cDNA (Giudice et
al, 1992; Li et al, 1993; Xu et al, 2000). A direct comparison of the
deduced amino acid sequences of hamster, human, mouse, and
canine type XVII collagen is depicted in Fig 2.
The identities of the total type XVII collagen amino acid
sequence of the hamster with those of the human and mouse were
76.4% and 89.4%, respectively, and the identity of the partial amino
acid sequence (709 amino acids) of the hamster with the canine
type XVII collagen was 82.2%. The antigenic site on the type XVII
collagen, however, was not conserved among the hamster, human,
mouse, and canine (Fig 2). The identities of the hamster with the
human, mouse, and canine were 57.5%, 71.8%, and 57.5%,
respectively. The amino acid sequences of the transmembranous
domain are identical among these species.
Characterization of rabbit antihamster type XVII collagen
antisera Reactivities of the rabbit antisera prepared against
peptides 1190 and 1191 were characterized by immunoblot
analysis. Antisera against peptide 1191 reacted with the 180 kDa
protein in hamster skin but anti-peptide 1190 antisera did not
(Fig 3). Therefore, the anti-1191 IgG (anti-hamster type XVII
collagen IgG) was puri®ed by using 1191-peptide columns.
Clinical evaluation of neonatal hamsters injected with anti-
1191 IgG Neonatal hamsters were intraperitoneally injected with
puri®ed anti-1191 IgG. Twenty-four hours after the injection, the
epidermis was lifted away from the dermis with tweezers in all
hamsters injected with over 0.2 mg anti-1191 IgG per g body
weight (Fig 4, arrows; Table I). One out of three hamsters injected
with 0.04 mg anti-1191 IgG per g body weight showed a
separation of the epidermis and dermis. The skin of the hamsters
injected with control rabbit IgG did not show any clinical signs or
separation in their skin (Table I).
Histologic and immunohistochemical studies of the skin of
the hamsters injected with anti-1191 IgG Histologic
examination revealed a narrow subepidermal cleft formation in
the skin of all the hamsters injected with over 0.2 mg anti-1191
IgG per g body weight (Fig 5a, arrows). These changes were also
evident in one of three hamsters injected with 0.04 mg anti-1191
IgG per g body weight.
In all hamsters injected with the anti-1191 IgG, rabbit IgG was
detected on the basement membrane zone (Fig 5b, arrows). C3
bound on the basement membrane zone was also observed in all
hamsters injected with 0.04 mg anti-1191 IgG per g and 0.2 mg
anti-1191 IgG per g body weight (Fig 5c, arrows; Table I). The
skin of hamsters injected with control rabbit IgG did not show any
pathogenic alteration (Fig 5d±f).
Figure 3. Reactivity of antipeptide 1191 antisera and antipeptide
1190 antisera with the 180 kDa protein of hamster skin extracts.
Hamster epidermal extract known to contain type XVII collagen was
separated on a 7.5% SDS polyacrylamide gel, and transferred to a PVP
membrane. The membrane was cut and incubated with rabbit anti-1191
peptide antisera, anti-1190 antisera, or control rabbit sera.
Figure 4. Separation of the DEJ of hamsters administered with
anti-1191 IgG. Neonatal hamsters were intraperitoneally injected with
IgG at doses from 0.04 to 5.0 mg anti-1191 IgG per g body weight. The
epidermis shown in this ®gure was obtained from a hamster injected
with 1.0 mg anti-1191 IgG per g body weight. The epidermis was easily
lifted away from the dermis with tweezers 24 h after injection (arrows).
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Effects of anti-1191 IgG and complement for DEJ separation
in vitro In order to examine the effects of anti-1191 IgG and
complement for DEJ separation in vitro, neonatal hamster skins
were incubated under various conditions as described in Materials
and Methods. Histologic examination of these tissues demonstrated
that, for DEJ separation, both anti-1191 IgG and complement were
required. Obviously there was no in¯ammatory cell attachment to
the basement membrane (Fig 6a, j, m, arrows). A deposition of IgG
was observed in the continual basement membrane zone (Fig 6b,
k, n, arrows). C3 was mainly detected in the basement membrane
zone over the subepidermal cleft (Fig 6c, l, o, arrows). In all hamster
skin strips incubated with anti-1191 IgG alone, fresh anti-1191
antisera preincubated with CVF, and puri®ed anti-1191 IgG plus
fresh normal rabbit sera preincubated with CVF, a deposition of
IgG was observed in the basement membrane zone (Fig 6e, h, q,
arrows). Neither DEJ separation nor C3 deposition in the basement
membrane zone was observed in the skin, however (Fig 6d, f, g, i,
p, r). Similar results were obtained when the skin strips were
incubated with heat-inactivated fresh anti-1191 antisera (data not
shown). There was no histologic change in any skin strip incubated
with control nonimmunized rabbit sera (data not shown).
DISCUSSION
We have cloned hamster type XVII collagen cDNA. The deduced
type XVII collagen polypeptide was calculated to have a molecular
mass of 145 kDa. It was estimated to be 180 kDa, however, based
on the mobility of SDS PAGE (Fig 3). This discrepancy could be
explained by post-translational modi®cations as shown in Fig 2.
It was reported that when antibodies to the mouse type XVII
collagen were passively transferred into neonatal BALB/c mice, the
Figure 5. Histologic examination of hamster skin injected with anti-1191 IgG or control IgG. The skins of hamsters injected with 5.0 mg
anti-1191 IgG per g body weight (a±c) or 5.0 mg control IgG per g body weight (d±f) were frozen in OCT compound and sectioned. The sections
were stained with hematoxylin and eosin (a, d), anti-rabbit IgG (b, e), or anti-human C3 (c, f). The skins of hamsters injected with anti-1191 IgG
showed a subepidermal cleft (a, arrows), an accumulation of IgG in the basement membrane zone over a subepidermal cleft (b, arrows), and a linear
deposition of C3 in the basement membrane zone (c, arrows). The skins of hamsters injected with control IgG did not show any pathologic change (d,
e, f). Neither IgG (e) nor C3 (f) were observed. Scale bar: 30 mm.
Figure 6. Effects of anti-1191 IgG and complement on DEJ separation in vitro. Skins from neonatal hamsters were incubated with fresh anti-
1191 antisera (a±c), puri®ed anti-1191 IgG plus DMEM medium (d±f), fresh anti-1191 antisera preincubated with CVF (g±i), heat-inactivated fresh anti-
1191 antisera plus normal rabbit serum (j±l), puri®ed anti-1191 IgG plus fresh normal rabbit sera (m±o), and puri®ed anti-1191 IgG plus fresh normal
rabbit sera preincubated with CVF (p±r).Sections were stained with hematoxylin and eosin (a, d, g, j, m, p), anti-rabbit IgG (b, e, h, k, n, q), or anti-
human C3 (c, f, i, l, o, r). Skins incubated with fresh anti-1191 antisera, heat-inactivated fresh anti-1191 antisera plus fresh normal rabbit sera, and
puri®ed anti-1191 IgG plus fresh normal rabbit sera showed a subepidermal cleft (a, j, m, arrows), IgG deposition (b, k, n, arrows), and C3 deposition in
the basement membrane zone over the subepidermal cleft (c, l, o, arrows). The skins incubated with anti-1191 IgG, fresh anti-1191 antisera preincubated
with CVF, and puri®ed anti-1191 IgG plus normal rabbit sera preincubated with CVF showed no pathologic change in the skin (d, g, p). Although
IgG deposition was observed in the basement membrane zone (e, h, q), no C3 deposition was detected (f, i, r). Scale bar: 30 mm (a, d±k, m, n, p, q),
12 mm (b, c, l, o, r).








Anti-hamster 5.0 2/2 2/2 1/2
type XVII 1.0 3/3 3/3 2/3
collagen IgG 0.2 3/3 3/3 3/3
0.04 1/3 3/3 3/3
Control IgG 5.0 0/2 0/2 0/2
a(Number of hamsters with skin separation)/(number of hamsters injected).
bNumerator and denominator represent the number of positive and injected
hamsters, respectively.
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antibodies induced a cutaneous blistering disease that reproduced all
of the clinical and immunopathologic features observed in human
BP (Liu et al, 1993). This DEJ separation triggered by pathogenic
antitype XVII collagen IgG could be due to the proteolytic
enzymes activated by complement and neutrophil recruitment (Liu
et al, 2000). In order to examine the DEJ separation mechanism in
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hamster BP, we obtained anti-hamster type XVII collagen
antibodies by injecting into rabbits two peptides (1190 and 1191)
in the antigenic site of the molecule. As only anti-1191 antisera
were found to react with hamster type XVII collagen, anti-1191
IgG was puri®ed from the antisera and used for pathogenic studies
of hamster BP. In neonatal hamsters injected with anti-1191 IgG,
the epidermis was lifted away from the dermis by tweezers.
Histologic examination demonstrated a narrow subepidermal cleft
formation of the skin in all hamsters injected with over 0.2 mg anti-
1191 IgG per g body weight. IgG was found to bind to the
basement membrane zone in all the anti-1191 IgG-injected
hamsters. C3 deposition in the basement membrane zone was
always detected in hamsters injected with low doses of anti-1191
IgG (0.04±0.2 mg per g body weight), but was not always seen in
hamsters injected with higher doses of anti-1191 IgG (1.0±5.0 mg
per g body weight). The higher doses of anti-1191 IgG and
complement produced more extensive damage to the basement
membrane and might destruct C3 in the basement membrane zone.
The contribution of neutrophils to the DEJ separation was reported
by using the in vitro system (Gammon et al, 1982). This showed that
when one of the leukocytes, pemphigoid antibodies, or fresh
human serum was omitted, signi®cantly less basement membrane
zone separation occurred.
We tested the possibility that antigen±antibody complexes and
complement components may initiate the DEJ separation. In order
to test this hypothesis, we incubated hamster skin with anti-1191
IgG in combination with sera containing active or inactive
complement system. In order to inactivate the complement system,
fresh anti-1191 antisera and fresh normal rabbit sera were either
inactivated with heat (at 56°C for 30 min) or preincubated with
CVF (at 37°C for 60 min). BP-like DEJ separation was observed
exclusively when the skin was incubated with anti-1191 IgG in sera
containing active complement system. Under these conditions,
both IgG and C3 were deposited on the basement membrane zone.
In the skin incubated with anti-1191 IgG alone, IgG but not C3
was deposited on the basement membrane zone; therefore DEJ
separation was not observed. An addition of sera whose comple-
ment system was inactivated with heat or CVF to anti-1191 IgG
caused IgG deposition, but neither C3 deposition on the basement
membrane zone nor epidermis±dermis detachment. It was shown
in these studies that both the anti-1191 IgG and complement
system were essential for DEJ separation. The anti-1191 IgG and
type XVII collagen complex were thought to activate the classical
pathway of complement in the sera, because C3 was deposited in
the basement membrane zone. Activated C3, in turn, produces the
terminal C5b-9 complement components on the basement mem-
brane zone to cause DEJ separation. It is likely that this DEJ
separation by anti-1191 IgG and complement is the initial step of
clinical blister formation, and proteolytic enzymes secreted by
neutrophils may work to enlarge the separation and blister
formation.
In summary, this study showed that rabbit antipeptide antibody
against the hamster counterpart of the human pemphigoid antigen
decreased dermal±epidermal cohesion and induced DEJ separation.
Histologic and immunohistochemical examination demonstrated a
narrow subepidermal cleft formation, and a deposition of IgG and
C3 in the basement membrane zone without leukocyte in®ltration.
Anti-hamster type XVII collagen IgG and complement started DEJ
separation in the absence of in¯ammatory cells. The decrease in
dermal±epidermal cohesion due to the IgG and complement
appears to play a key role in the pathogenic cascade leading to
blister formation.
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